REVLIMID

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug REVLIMID contains one active pharmaceutical ingredient (API):

1 Lenalidomide UNII F0P408N6V4 - LENALIDOMIDE

The lenalidomide mechanism of action includes anti-neoplastic, anti-angiogenic, pro-erythropoietic, and immunomodulatory properties. Read about Lenalidomide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
REVLIMID Capsules	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AX04	Lenalidomide	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants
Discover more medicines within L04AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11029L, 11036W, 11041D, 11042E, 11055W, 11062F, 11063G, 11064H, 11964Q, 11965R, 11966T, 11967W, 11968X, 11969Y, 12004T, 12011E, 12012F, 12018M, 12019N, 12020P, 12026Y, 12034J, 12035K, 12036L, 12037M, 12038N, 12039P, 12050F, 12057N, 12058P, 12059Q, 12060R, 12061T, 12062W, 12068E, 12069F, 12070G, 12071H, 2796E, 2798G, 2799H, 2802L, 5783J, 5784K, 5785L, 5786M, 9642L, 9643M, 9644N, 9645P
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 562418040000102, 562418040000202, 562418040000302, 562418040000402, 562419060000701, 562419060000801, 562420020001007, 562420020001107, 562420020001207, 562420020001307, 562420020001407
Country: CA	Health Products and Food Branch	Identifier(s): 02304899, 02304902, 02317699, 02317710, 02440601, 02459418
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29022-09-09, 29024-09-09, 29025-09-09, 29026-09-09, 3161-MEE-0218
Country: EE	Ravimiamet	Identifier(s): 1299540, 1299551, 1299562, 1299573, 1594199, 1594201, 1618938, 1618949, 1677764, 1739796, 1739864, 1796261, 1796272, 1796283
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07391001, 07391002, 07391003, 07391004, 107391009
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 096524, 096533, 096542, 096551, 471032, 524729
Country: FR	Base de données publique des médicaments	Identifier(s): 60245253, 63841924, 65512525, 65786896, 67232333, 68425602, 69470867
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 117555, 117558, 117561, 117566, 233076, 298952, 298955
Country: HK	Department of Health Drug Office	Identifier(s): 59190, 59191, 59192, 59193, 62180, 62181, 62182, 62183
Country: IE	Health Products Regulatory Authority	Identifier(s): 88008, 88717, 88729, 88781, 88932
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6275, 6276, 6277, 6278
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291024M1024, 4291024M2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030700, 1030701, 1030702, 1030703, 1067916, 1067917, 1072173, 1072174, 1076825, 1083709, 1083710, 1088013, 1088014
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 101M2010
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 113387, 125733, 125741, 83909, 83917, 83925, 83933
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13398, 13399, 13400, 13401, 18134, 18135, 18136
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100069827, 100147220, 100148082, 100153019, 100315887, 100315901, 100382553
Country: SG	Health Sciences Authority	Identifier(s): 13662P, 13663P, 13664P, 13665P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 13483021H, 13483022H, 13483023H, 13483024H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699538154822, 8699538154839, 8699538154846, 8699538154853
Country: US	FDA, National Drug Code	Identifier(s): 59572-402, 59572-405, 59572-410, 59572-415, 59572-420, 59572-425
Country: ZA	Health Products Regulatory Authority	Identifier(s): 47/32/0507, 47/32/0508, 47/32/0509, 47/32/0510